Login to Your Account

Troubled Valentis Finds Merger Opportunity With Private Urigen

By Jennifer Boggs

Tuesday, October 10, 2006
Valentis Inc., which began talking of sale or merger options three months ago following negative data from a Phase IIb study of its lead candidate in peripheral arterial disease, has agreed to merge with neighboring firm Urigen N.A. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription